32 results match your criteria nonpigmenting


Nonpigmenting and pigmenting fixed drug eruptions due to clarithromycin.

Contact Dermatitis 2021 Jun 15. Epub 2021 Jun 15.

Department of Dermatology, Osaka City University Graduate School of Medicine, Osaka, Japan.

View Article and Full-Text PDF

Desquamating Nonpigmenting Fixed Drug Eruption With Onycholysis due to Amoxicillin in a Child: Cross-reactivity Study.

J Investig Allergol Clin Immunol 2020 Apr 21;30(2):149-151. Epub 2019 Nov 21.

Hospital Infantil Universitario Niño Jesús, Madrid, Spain.

View Article and Full-Text PDF

Bullous nonpigmenting multifocal fixed drug eruption due to pseudoephedrine in a combination drug: clinical and diagnostic observations.

J Allergy Clin Immunol Pract 2016 May-Jun;4(3):542-4. Epub 2016 Jan 12.

Clinical, Allergological and Venereological Dermatology Section, Department of Medicine, University of Perugia, Perugia, Italy. Electronic address:

View Article and Full-Text PDF

Pseudoephedrine may cause "pigmenting" fixed drug eruption.

Dermatitis 2011 May;22(3):E7-9

Department of Dermatology, Istanbul Medical Faculty, Turkey.

Fixed drug eruption (FDE) is a distinctive drug eruption characterized by recurrent well-defined lesions in the same location each time the responsible drug is taken. Two different clinical forms have been described: the common classic pigmenting form and the rare nonpigmenting form. Nonpigmenting FDE is mainly characterized by symmetrical large erythematous plaques and the dermal histopathologic reaction pattern. Read More

View Article and Full-Text PDF

Nonpigmenting fixed drug eruption as a possible abortive variant of toxic epidermal necrolysis: immunohistochemical and serum cytokine analyses.

Clin Exp Dermatol 2010 Jul 23;35(5):493-7. Epub 2009 Oct 23.

Department of Dermatology, Kyorin University School of Medicine, Tokyo, Japan.

Nonpigmenting fixed drug eruption (NPFDE) is clinically indistinguishable from Stevens-Johnson syndrome (SJS) or toxic epidermal necrolysis (TEN) in its initial presentation. The traditional paradigm that epidermal changes are absent in NPFDE cannot be easily reconciled with the clinical resemblance to SJS/TEN. We therefore investigated whether NPFDE is pathogenetically different from pigmented FDE (PFDE) or SJS/TEN and which factors are responsible for the lack of hyperpigmentation. Read More

View Article and Full-Text PDF

Vulvar fixed drug eruption. A report of 13 cases.

Authors:
Gayle Fischer

J Reprod Med 2007 Feb;52(2):81-6

Department of Dermatology, Royal North Shore Hospital, St. Leonard's, Sydney, Australia.

Background: The fixed drug eruption (FDE) is an uncommon adverse event related to drug ingestion that presents with a recurrent eruption occurring on the same site with each drug exposure. The genital area is a well-recognized site for the so-called nonpigmenting fixed drug eruption. Most of the medical literature has focused on the male genitalia. Read More

View Article and Full-Text PDF
February 2007

Nonpigmenting confluent and reticulated papillomatosis.

Pediatr Dermatol 2006 Sep-Oct;23(5):497-9

University of Pennsylvania Medical Center, Philadelphia, Pennsylvania, USA.

We report three teenaged Caucasian patients with confluent and reticulated papillomatosis whose presentation was atypical due to the absence of hyperpigmentation and presence of a fine white scale. Read More

View Article and Full-Text PDF
January 2007

Furazolidone induced nonpigmenting fixed drug eruptions affecting the palms and soles.

Authors:
C Tan W Y Zhu

Allergy 2005 Jul;60(7):972-4

Department of Dermatology First Affiliated Hospital of Nanjing University of TCM, Hanzhong Road Nanjing China 210029.

View Article and Full-Text PDF

Nonpigmenting solitary fixed drug eruption caused by a Chinese traditional herbal medicine, ma huang (Ephedra Hebra), mainly containing pseudoephedrine and ephedrine.

J Am Acad Dermatol 2003 Apr;48(4):628-30

Department of Dermatology, Shinshu University School of Medicine, Matsumoto, Japan.

We describe a case of nonpigmenting solitary fixed drug eruption appearing on the right thigh of a 31-year-old woman in Japan. The causative drug was determined by closed patch test on postlesional skin as a Chinese traditional herbal medicine, ma huang (Ephedra Hebra), mainly containing pseudoephedrine and ephedrine. Read More

View Article and Full-Text PDF

Fixed drug eruptions. Incidence, recognition, and avoidance.

Authors:
A Y Lee

Am J Clin Dermatol 2000 Sep-Oct;1(5):277-85

Department of Dermatology, Eulji Hospital College of Medicine, Seoul, South Korea.

Drug eruptions often have nonspecific clinical findings, and the evaluation of the probability of an eruption being a drug-induced event is difficult. A few types of drug eruption do not present such problems, and the fixed drug eruption is one of those whose clinical findings are specific enough to allow a diagnosis. The fixed drug eruption is a commonly reported type of drug eruption. Read More

View Article and Full-Text PDF

Nonpigmenting solitary fixed drug eruption after skin testing and intra-articular injection of triamcinolone acetonide.

Ann Allergy Asthma Immunol 2001 Mar;86(3):335-6

Department of Allergy, Gülhane Military Medical Academy, Ankara, Turkey.

Background: Although several medications have been reported to cause fixed drug eruption (FDE) reactions, triamcinolone acetonide has not been previously described as an offending agent.

Objective: To emphasize both an unprecedented causative agent and the extraordinary development of a FDE, we describe this response in a 42-year-old female patient.

Methods: Because her history included a questionable reaction to corticosteroid preparations, prick and intradermal testing with triamcinolone acetonide was done to determine whether she could safely receive a triamcinolone acetonide injection. Read More

View Article and Full-Text PDF

Drug related clinical pattern in fixed drug eruption.

Eur J Dermatol 2000 Jun;10(4):288-91

Department of Dermatology, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey.

Fixed drug eruption (FDE) represents a frequent type of drug eruption in Turkey. The aim of this open study is to analyze the clinical features with special emphasize on drug related pattern in our case series. Sixty-four cases with established FDE by oral provocation were clinically evaluated. Read More

View Article and Full-Text PDF

Drugs causing fixed eruptions: a study of 450 cases.

Int J Dermatol 1998 Nov;37(11):833-8

Department of Dermatology, King Edward Medical College/Mayo Hospital, Lahore, Pakistan.

Background: Drug eruptions are among the most common cutaneous disorders encountered by the dermatologist. Some drug eruptions, although trivial, may cause cosmetic embarrassment and fixed drug eruption (FDE) is one of them. The diagnostic hallmark is its recurrence at previously affected sites. Read More

View Article and Full-Text PDF
November 1998

Nonpigmenting fixed drug eruption due to pseudoephedrine.

Ann Allergy Asthma Immunol 1998 Apr;80(4):309-10

Allergy Unit, Complejo Hospitalario Universitario de Santiago de Compostela (Hospital de Conxo), Spain.

Background: The nonpigmenting fixed drug eruption is a distinctive drug reaction characterized by large, tender and symmetric erythematous plaques that disappear with no residual pigmentation.

Methods: A case of a non-pigmenting fixed drug eruption due to pseudoephedrine is reported.

Result: The reappearance of typical lesions at the same sites after oral challenge with 60 mg pseudoephedrine together with the absence of pigmentation confirm the diagnosis. Read More

View Article and Full-Text PDF

Nonpigmenting solitary fixed drug eruption caused by pseudoephedrine hydrochloride.

J Am Acad Dermatol 1998 Mar;38(3):499-500

Department of Dermatology, Hacettepe University Faculty of Medicine, Ankara, Turkey.

View Article and Full-Text PDF

Recently described clinically important anaerobic bacteria: taxonomic aspects and update.

Clin Infect Dis 1997 Sep;25 Suppl 2:S78-87

Anaerobe Reference Laboratory, National Public Health Institute, Helsinki, Finland.

A new method of identifying bacteria, phylogenetic 16S rRNA sequencing, has led to major reorganizations among most genera of anaerobic bacteria. The pigmented Prevotella species now comprise seven species including P. nigrescens and P. Read More

View Article and Full-Text PDF
September 1997

Nonpigmenting fixed exanthema from ephedrine and pseudoephedrine.

Allergy 1997 Feb;52(2):229-30

Hospital Los Montalvos, Servicio de Alergia, Salamanca, Spain.

View Article and Full-Text PDF
February 1997

Nonpigmenting fixed drug eruption after pseudoephedrine.

Authors:
M B Quan W C Chow

Int J Dermatol 1996 May;35(5):367-70

Department of Dermatology, University of California, Davis School of Medicine, Sacramento, USA.

View Article and Full-Text PDF

Rapid characterization of periodontal bacterial isolates by using fluorogenic substrate tests.

J Clin Microbiol 1996 Feb;34(2):376-84

Department of Periodontal Microbiology, Forsyth Dental Center, Boston, Massachusetts 02115, USA.

Eighty-nine species of subgingival bacteria, represented by 121 reference strains and 892 patient isolates, including gram-negative, gram-positive, aerobic, facultatively anaerobic, microaerophilic, and anaerobic species, were characterized with a panel of fluorogenic, 4-methylumbelliferyl-linked substrate tests. Identifications of all patient isolates were confirmed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) of whole-cell proteins relative to reference strains. Characteristic profiles of positive fluorogenic reactions differentiated most of the species, including five Porphyromonas species, six pigmenting and five nonpigmenting Prevotella species, Bacteroides forsythus, three Capnocytophaga species, six Actinomyces species, four Propionibacterium species, and eight Streptococcus species. Read More

View Article and Full-Text PDF
February 1996

Nonpigmenting fixed drug eruption: a new case due to betahistine.

Dermatology 1996 ;193(3):248-50

Department of Dermatology-Phlebology, CHRU Montpellier, France.

We describe a new case of a seldom reported subset of fixed drug eruption, the nonpigmenting type. Aside from their fixed nature and their well-demarcated margins, pigmenting and non-pigmenting subsets of fixed drug eruption exhibit well-separated clinical and histological features allowing easy recognition. The precise physiopathology is currently unknown in both conditions, but a delayed hypersensitivity mechanism is likely. Read More

View Article and Full-Text PDF

Nonpigmenting fixed drug eruption.

J Am Acad Dermatol 1994 Aug;31(2 Pt 1):291-2

Dermatology Service, Walter Reed Army Medical Center.

View Article and Full-Text PDF

Guidelines for the treatment of vitiligo.

Drugs 1992 Apr;43(4):490-8

University of Athens, School of Medicine, Department of Dermatology, Greece.

At present, there is no universally effective drug for vitiligo therapy; there are, however, various therapeutic modalities that may be beneficial. Therapeutic regimens used to treat vitiligo include psoralens and ultraviolet A light (PUVA), topical corticosteroids, fluorouracil locally applied with skin abrasion, a variety of surgical techniques to transplant autologous melanocytes from pigmented skin to nonpigmenting areas, a new photochemotherapeutic regimen using oral khellin with UVA phototherapy, and a recently proposed treatment with oral phenylalanine in combination with UVA exposure. PUVA and topical corticosteroids are the 2 most frequently used modalities. Read More

View Article and Full-Text PDF

Nonpigmenting fixed drug eruption caused by diflunisal.

J Am Acad Dermatol 1991 Jun;24(6 Pt 1):1021-2

Department of Family Medicine, University of South Florida, Tampa 33612.

View Article and Full-Text PDF

Transient, nonpigmenting fixed drug eruption caused by radiopaque contrast media.

J Am Acad Dermatol 1990 Aug;23(2 Pt 2):379-81

Dermatology Service, Walter Reed Army Medical Center.

A unique case of a transient, nonpigmenting fixed drug eruption caused by the radiopaque contrast medium iothalamate is reported. The patient had on the medial aspect of the thigh a fixed solitary, recurrent, indurated, erythematous plaque, which resolved within 2 days. The scant literature available on nonpigmenting fixed drug eruptions is reviewed. Read More

View Article and Full-Text PDF

Nonpigmenting fixed drug eruption after anesthesia.

Authors:
H Desmeules

Anesth Analg 1990 Feb;70(2):216-7

Département d'anesthésie-réanimation, Centre hospitalier de l'Université Laval, Sainte-Foy, Québec, Canada.

View Article and Full-Text PDF
February 1990

Nonpigmenting fixed drug reaction to piroxicam.

J Am Acad Dermatol 1989 Dec;21(6):1300

Department of Dermatology, Ospedali Riuniti, Bergamo, Italy.

View Article and Full-Text PDF
December 1989

Nonpigmenting fixed drug eruption as a distinctive reaction pattern: examples caused by sensitivity to pseudoephedrine hydrochloride and tetrahydrozoline.

J Am Acad Dermatol 1987 Sep;17(3):403-7

Department of Medicine, Medical College of Ohio, Toledo 43699.

Nonpigmenting fixed drug eruption is a distinctive, clinically recognizable entity. Characteristically, the lesions are large, symmetrical, well-circumscribed tender erythematous plaques that suddenly appear and reappear in exactly the same sites. They fade without pigmentation or any other trace over a 2- to 3-week period. Read More

View Article and Full-Text PDF
September 1987